![Adrienne Farid](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Adrienne Farid
Geen lopende functies
Vermogen: 612 845 $ op 31-05-2026
Profiel
Adrienne Farid worked at Roche Pharmaceuticals, Inc. from 1995 to 2011 as Global Head-Project & Portfolio Management.
From 2014 to 2017, worked at Celgene Corp.
as VP-Project Leadership.
Served as Director at Carisma Therapeutics, Inc. Worked at Century Therapeutics, Inc. from 2021 to 2025 as Chief Development Officer & Head-Early Development from 2024 to 2025.
Education includes a doctorate from The Trustees of Columbia University in The City of New York and an undergraduate degree from Barnard College.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-03-2026 | 250.141 ( 0,14% ) | 612 845 $ | 31-05-2026 |
Eerdere bekende functies van Adrienne Farid
| Bedrijven | Functie | Einde |
|---|---|---|
| CENTURY THERAPEUTICS, INC. | Operationeel Directeur | 01-10-2024 |
| CELGENE | Corporate Officer/Principal | 01-07-2017 |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Corporate Officer/Principal | 01-01-2011 |
| CARISMA THERAPEUTICS, INC. | Directeur/Bestuurslid | - |
Opleiding van Adrienne Farid
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
42
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Commercial Services |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Barnard College
 Barnard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Century Therapeutics, Inc.
 Century Therapeutics, Inc. BiotechnologyHealth Technology Develops novel allogeneic living drugs for oncology that overcome the limitations of first-generation cell therapies | Health Technology |
Carisma Therapeutics, Inc.
 Carisma Therapeutics, Inc. BiotechnologyHealth Technology Develops novel chimeric antigen receptor macrophage and CAR-monocyte technology treatment of non-muscle invasive bladder cancer | Health Technology |
